Drug that claims to kill the flu in a day approved in Japan
Japan on Friday approved a drug that claims to kill the flu in 24 hours, a move that could be a major breakthrough in combating the way influenza is treated.
The Japanese drug maker Shionogi can begin selling its pill, called Xofluza, locally but it wouldn't hit U.S. shelves until at least 2019, the Wall Street Journal reports. The tablet was approved by Japan's Ministry of Health.
That's unfortunate since the U.S. is in the grips of the worst flu season in a decade, with a total of 97 child deaths. This harsh flu season remains widespread in 48 states, according to the Center for Disease Control and Prevention's latest report Friday.
The price of the pill? The national insurer has yet to set one meaning that the drug may not be available in Japan until at least May, according to the Wall Street Journal.
Xofluza has been touted as a potential rival to Tamiflu, a drug available in capsule and liquid form that requires the patient to take it twice daily for five days.